Schedule 13G ownership disclosure

Coherus Oncology Inc

Security class unavailable · CUSIP: 19249H103

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
5,815,882
Percent of class
7.4800%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-23-015665
Form type
SC 13G/A
Filer
Coherus Oncology, Inc.
CIK
CIK 1512762
Filed
Feb 09, 2023
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub